Drug name - Lupron Depot

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8921326 ABBVIE ENDOCRINE INC Sustained-release composition and method for producing the same Feb, 2031

(8 years from now)

Drugs and Companies using LEUPROLIDE ACETATE ingredient

Treatment: Palliative treatment of prostate cancer

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
22.5MG/VIAL INJECTABLE;INJECTION Prescription
30MG/VIAL INJECTABLE;INJECTION Prescription
45MG/VIAL INJECTABLE;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.